Harry Lander

Harry Lander

Chief Executive Officer at Canary Oncoceutics, Inc.

Net worth: 193 613 $ as of 2024-03-30

58 year
Consumer Services
Health Technology
Health Services

Profile

Harry M.
Lander
is currently the Chief Executive Officer at Canary Oncoceutics, Inc., the Director at Federation Employment & Guidance Service, Inc., and the Director at Capo Therapeutics, Inc. Previously, he held the position of President, Director & Chief Scientific Officer at Zander Therapeutics, Inc. from 2018 to 2019, and President & Chief Scientific Officer at Regen Biopharma, Inc. from 2015 to 2019.
He also served as the Head-Administration at Sidra Medical & Research Center.
In addition, he will be the Chief Scientific Officer at SYBLEU, Inc. from 2022 to 2024.
Dr. Lander obtained his undergraduate degree from Stony Brook University.
He also holds an MBA from The Leonard N Stern School of Business, which he received in 1991.
Furthermore, he earned a doctorate degree from Weill Cornell Graduate School of Medical Sciences in 1992.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-07-30 3,309,000 ( 31.18% ) 188 613 $ 2024-03-30
2023-11-05 6,667 ( 0.02% ) 5 000 $ 2024-03-30

Harry Lander active positions

CompaniesPositionStart
Director/Board Member 2009-09-15
Director/Board Member -
Chief Executive Officer -
All active positions of Harry Lander

Former positions of Harry Lander

CompaniesPositionEnd
SYBLEU INC. Chief Tech/Sci/R&D Officer 2024-04-11
REGEN BIOPHARMA, INC. President 2019-01-21
President 2019-01-21
Chief Administrative Officer -
See the detail of Harry Lander's experience

Training of Harry Lander

Stony Brook University Undergraduate Degree
The Leonard N Stern School of Business Masters Business Admin
Weill Cornell Graduate School of Medical Sciences Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Harry Lander's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies7
Regen Biopharma, Inc.

Health Services

Commercial Services

Health Technology

Health Technology

SYBLEU, Inc.

Health Technology

See company connections